Navigation Links
USP announces 11 new proposed monographs for dietary supplements
Date:11/15/2007

Rockville, Md., November 15, 2007 The U.S. Pharmacopeia (USP) is pleased to announce 11 new proposed monographs for dietary supplements for public notice and comment.

Six Turmeric-related monographs and three Soy Isoflavones monographs appeared in Pharmacopeial Forum (PF) 33(6), the issue corresponding to November/December 2007. These are Turmeric, Powdered Turmeric, Powdered Turmeric Extract, Curcuminoids, Curcuminoids Capsules, Curcuminoids Tablets, Soy Isoflavones Extract, Soy Isoflavones Capsules, and Soy Isoflavones Tablets. Two monographs for single ingredient amino acid formulations, arginine capsules and arginine tablets also appeared in PF 33(6). PF is the journal through which USP offers, for public review and comments, new and revised standards pertaining to the United States PharmacopeiaNational Formulary.

USP is pleased to release these new monographs in addition to the proposed monographs on Powdered Decaffeinated Green Tea Extract and Powdered Bilberry Extract published recently in PF 33(4) in July 2007, said Darrell Abernethy, M.D., Ph.D., chief science officer at USP. This is an important step towards advancing the quality of these dietary supplements, which are increasingly used by consumers. USP welcomes comments on the new monographs from all interested parties.

The proposed monographs contain specific and validated analytical methods that will ensure the identity of the articles and protect consumers and industry from low quality and adulterated products. For example, the proposed monograph on Powdered Bilberry Extract distinguishes the true extract from articles adulterated with azo dyes and other anthocyanin-containing botanicals. Green Tea, Turmeric and Soy Isoflavones monographs were also the subjects of a number of the 2006 National Institutes of Health research grants.

All 11 monographs address articles that are of great interest to the dietary supplements industry and to the scientific community.


'/>"/>

Contact: Sandra Kim
sek@usp.org
301-816-8241
US Pharmacopeia
Source:Eurekalert

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to ... to save lost souls in the Philippines. “The Journey: From the Mountains to the ... teacher of the Bible. She has taught all ages and currently teaches a class ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... introduction of an innovative new design of the shoulder pad. The shoulder pad ... comfort while controlling your pain while using cold therapy. By utilizing ice and water ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts ... Washington, D.C., for the 49th Congress of the International Society of Paediatric Oncology ... of the Center for Cancer and Blood Disorders at Children’s National, and ...
Breaking Medicine News(10 mins):
(Date:9/22/2017)... Sept. 22, 2017 AVACEN Medical (AVACEN) announced ... now successfully helping those with the widespread pain associated ... diagnosed Amanda in Essex, England ... my hair, experiencing no sleep at all, tremendous pain, ... I cannot recommend [the AVACEN 100] enough, how this ...
(Date:9/18/2017)... , Pa. and KALAMAZOO, Mich. , ... Allentown, Penn. , and OptiMed Specialty Pharmacy of ... business partnership to offer a strategic hub service that ... Healthcare,s highly sought-after personal spirometer, Spiro PD 2.0, and ... A spirometer is a medical device used to ...
(Date:9/12/2017)... PARIS and NEW YORK , Sept. 12, ... ethical performance ratings for global supply chains, has published the first annual ... the CSR performance of more than 20,400 companies evaluated by EcoVadis, based ... years 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
Breaking Medicine Technology: